ARCHIVES

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

Cancer Meetings Listed for Next Three Months

January 19, 1996

RFA: Clinical Correlative Studies In Solid Tumors

April 3, 1992

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999

“Too much [of NCI’s] planning is reactive rather than proactive. As a consequence, vision suffers.”

July 7, 1995

Commercial Labs Open Drive To Get More NIH Business, Including Grants

April 26, 1974

QOL Of Young Survivors Equal To Other Children

February 25, 2005